109908 ⎘
dsDNA viruses; Details; Herpesviridae; Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
VARICELLA-ZOSTER VIRUS IMMUNOGEN COMPOSITIONS AND THEIR USES
#2TRUNCATED VARICELLA-ZOSTER VIRUS ENVELOPE GLYCOPROTEIN GE
#3ANTIGEN DELIVERY PLATFORMS
#4NUCLEIC ACID VACCINES FOR VARICELLA ZOSTER VIRUS (VZV)
#5IMMUNOGENICITY OF A CPG-ADJUVANTED HERPES ZOSTER VACCINE
#6VARICELLA ZOSTER VIRUS (VZV) VACCINE
#7PSEUDORABIES VIRUS (PRV) EXPRESSING PORCINE CIRCOVIRUS 2 (PCV2) CAPSID PROTEIN ON ENVELOPE AND USE THEREOF
#8CHIMERIC VIRUS-LIKE PARTICLES AND USES THEREOF AS ANTIGEN-SPECIFIC REDIRECTORS OF IMMUNE RESPONSES
#9PHARMACEUTICAL COMPOSITIONS FOR DELIVERY OF VIRAL ANTIGENS AND RELATED METHODS
#10COMPOSITIONS, METHODS, MODELS AND USES FOR SIMIAN VARICELLA VIRUS (SVV) CHIMERIC CONSTRUCTS IN HUMAN HEALTH CONDITIONS
#11Genetically Modified Bovine Herpesvirus Type 1 (BHV-1) for use to Treat Cancer
#12BVP8 PROTEIN FOR KILLING TETRANYCHID MITES AND USE THEREOF
#13Varicella zoster virus (VZV) vaccine
#14RECOMBINANT NUCLEIC ACIDS CONTAINING ALPHAHERPESVIRUS PROMOTER SEQUENCES
#15Recombinant varicella-zoster virus (VZV) vaccine
#16Chimeric virus-like particles and uses thereof as antigen-specific redirectors of immune responses
#17Recombinant virus with diminished latency and methods of using same
#18Antigen delivery platforms
#19Antigen variant of Varicella Zoster virus and use thereof
#20ORF7 deficient varicella virus, vaccine comprising the virus and use thereof
#21Non-neuroinvasive viruses and uses thereof
#22Non-neuroinvasive viruses and uses thereof
#23Chimeric virus-like particles and uses thereof as antigen-specific redirectors of immune responses
#24Varicella zoster virus (VZV) vaccine
#25Recombinant virus with diminished latency and methods of using same
#26Antigen delivery platforms
#27Subunit vaccine of porcine pseudorabies virus and preparation method
#28ORF7 deficient varicella virus, vaccine comprising the virus and use thereof
#29Non-neuroinvasive viruses and uses thereof
#30Nucleic acid molecules encoding novel herpes antigens, vaccine comprising the same, and methods of use thereof
#31Porcine pseudorabies virus, vaccine composition and preparation method and use thereof
#32Herpes simplex virus (HSV) with modified tropism, uses and process of preparation thereof
#33Conditionally replication deficient herpes virus and use thereof in vaccines
#34Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof
#35Newcastle disease virus vectored herpesvirus vaccines
#36ORF7 deficient varicella virus, vaccine comprising the virus and use thereof
#37Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof
#38Recombinant virus with diminished latency and methods of using same
#39HERPES VIRUS BACKBONE FOR VIRAL VACCINE AND VACCINE BASED THEREON
#40Newcastle disease virus vectored herpesvirus vaccines
#41Bovine herpes virus-1 compositions, vaccines and methods
#42Herpes simplex virus (HSV) with modified tropism, uses and process of preparation thereof
#43Recombinant Varicella-Zoster Virus
#44Vaccine against varicella zoster virus
#45VACCINE AGAINST VARICELLA ZOSTER VIRUS
#46Cattle reproductive disease vaccines
#47NUCLEIC ACID CONSTRUCTS
#48TRANSGENIC ONCOLYTIC VIRUSES AND USES THEREOF
#49Eukaryotic layered vector initiation systems
#50USE OF A VARICELLOVIRUS TAP-INHIBITOR FOR THE INDUCTION OF TUMOR-OR VIRUS-SPECIFIC IMMUNITY AGAINST TEIPP
#51Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus
#52USE OF RECOMBINANT ANTIGENS TO DETERMINE THE IMMUNE STATUS OF AN ANIMAL
#53Genetically engineered cell lines and systems for propagating varicella zoster virus and methods of use thereof
#54Compositions and Methods for Elimination of Unwanted Cells
#55Compositions and Methods for Elimination of Unwanted Cells
#56Immunodeficiency recombinant poxvirus
#57Recombinant Vaccine from gE, gI, and gB Proteins of the Varicella-Zoster Virus for the Treatment and Prevention of Multiple Sclerosis
#58Vaccine
#59Compositions and Methods for Elimination of Unwanted Cells
#60Compositions and methods for elimination of unwanted cells
#61Nucleic acid constructs
#62gM-negative EHV-mutants
#63Recombinant feline herpesvirus type 1 and polyvalent vaccine using the same
#64Cattle reproductive disease vaccines
#65Canine herpesvirus thymidine kinase nucleic acid molecules
#66Recombinant vaccine from gE, gI, and gB proteins of the varicella-zoster virus for the treatment and prevention of multiple sclerosis
#67Genetically engineered cell lines and systems for propagating virus and methods of use thereof
#68Compositions and methods for elimination of unwanted cells
#69Recombinant live vaccine based on canine herpesvirus, in particular against Carre's disease, rabies or the parainfluenza virus type 2.
#70Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use
#71Fusion proteins comprising carriers that can induce a dual immune response
#72Recombinant feline herpesvirus type 1 and polyvalent vaccine using the same
#73Viral marker
#74Nucleic acid vaccines for varicella zoster virus (VZV)